I have compiled some of the DD here for ROIX Joseph Clark recently resigned and upon the resignation the stock fell from a $3.00 level to -$1.00
I am of the belief that upon the appointment of a new CEO the stock will regain it previous level making it an excellent investment at this time. Dr. West is currently filling the position of CEO and is truly the moving force behind this organization. Follow the URL?s below to the PR?s and do your own DD, I thing you will find this a good investment.
PR URL:
siliconinvestor.com
ROIX is a comprehensive cancer management co. that provides advanced cancer treatment services, manages the practices of oncologists, and conducts cancer research on behalf of pharmaceutical companies. For the 9 months ended 9/98, revenues rose 24% to $94.1M. Net income rose 24% to $3.9M. Revenues reflect an increase in revenue from the practice management division. Earnings reflect a decrease in interest expense and provision for doubtful accounts.
Response Oncology, Inc.
1775 Moriah Woods Blvd.
Memphis, TN 38117
Phone: (901) 761-7000
Fax: (901) 763-7045
Employees: 425
Officers:
William H. West, Chmn.,
Frank M. Bumstead, Vice Chmn.,
Joseph T. Clark, Pres./CEO,
Mary E. Clements, Exec. VP-Fin./CFO,
Kenneth L. Scott, COO.
Sales (TTM): 128.25M |
